STEMdiff Monocyte Differentiation Supp

Monocyte lineage commitment from hematopoietic progenitors and peripheral blood precursors depends on a defined cytokine and small-molecule environment. STEMCELL Technologies offers this additive to supplement a base medium such as StemSpan SFEM II, driving in vitro generation of CD14+ monocytic populations that can be carried forward into macrophage or dendritic cell differentiation protocols.

The supplement arrives frozen and should remain at -20 degrees C until first use; thaw briefly and aliquot to limit repeated freeze-thaw cycles. Each single-use vial is sized for a defined working volume of base medium and supports both small-scale characterization studies and larger production runs for downstream applications such as flow cytometry phenotyping, phagocytosis assays, and T-cell co-culture experiments.

Intended for research use only, the reagent fits standard cell culture workflows and is compatible with the STEMdiff medium family. Investigators in immunology, inflammation, and oncology routinely employ the resulting monocyte-derived cells to model host-pathogen interactions, screen candidate immunomodulators, and explore myeloid lineage biology under controlled in vitro conditions.